Serum Institute inks deal with American vaccine maker Novavax after Oxford-AstraZeneca: What we know
https://ift.tt/2Dhr0c1
Serum Institute of India (SII), which has signed deal to manufacture Oxford-AstraZeneca coronavirus vaccine, has now entered into an agreement with American vaccine developer Novavax Inc. American developer Novavax and Serum Institute entered inked agreement on July 30 for development, co-formulation, filling and finishing, registration and commercialisation of the Novavax vaccine -- NVX-CoV2373. Novavax, in the early stage human trials conducted on over 50 people showed "elicited robust antibody responses."
Serum Institute of India (SII), which has signed deal to manufacture Oxford-AstraZeneca coronavirus vaccine, has now entered into an agreement with American vaccine developer Novavax Inc. American developer Novavax and Serum Institute entered inked agreement on July 30 for development, co-formulation, filling and finishing, registration and commercialisation of the Novavax vaccine -- NVX-CoV2373. Novavax, in the early stage human trials conducted on over 50 people showed "elicited robust antibody responses."
No comments